Literature DB >> 12502629

Diabetic nephropathy.

Mark E Molitch, Ralph A DeFronzo, Marion J Franz, William F Keane, Carl Erik Mogensen, Hans-Henrik Parving.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12502629     DOI： 10.2337/diacare.26.2007.s94

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  79 in total

1.  Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging.

Authors:  Georgios I Papaioannou; Christos Kasapis; Richard L Seip; Neil J Grey; Deborah Katten; Frans J Th Wackers; Silvio E Inzucchi; Samuel Engel; Amy Taylor; Lawrence H Young; Deborah A Chyun; Janice A Davey; Ami E Iskandrian; Robert E Ratner; Evelyn C Robinson; Stella Carolan; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

2.  Higher mitochondrial DNA copy number is associated with lower prevalence of microalbuminuria.

Authors:  Jung Eun Lee; Hansoo Park; Young Seok Ju; Minhye Kwak; Jong Il Kim; Ha Young Oh; Jeong Sun Seo
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

3.  Reducing the Economic and Clinical Burden Of CKD in the Managed Care Setting.

Authors:  Samir H Mody
Journal:  Biotechnol Healthc       Date:  2004-10

4.  Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

Authors:  T M E Davis; R Ting; J D Best; M W Donoghoe; P L Drury; D R Sullivan; A J Jenkins; R L O'Connell; M J Whiting; P P Glasziou; R J Simes; Y A Kesäniemi; V J Gebski; R S Scott; A C Keech
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

5.  Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria.

Authors:  Athanasia Papazafiropoulou; Ioannis Daniil; Alexios Sotiropoulos; Eleni Balampani; Anthi Kokolaki; Stavros Bousboulas; Stavroula Konstantopoulou; Eystathios Skliros; Dimitra Petropoulou; Stavros Pappas
Journal:  BMC Res Notes       Date:  2010-06-17

6.  Thickness of glomerular and tubular basement membranes in preclinical and clinical stages of diabetic nephropathy.

Authors:  I Tyagi; U Agrawal; V Amitabh; A K Jain; S Saxena
Journal:  Indian J Nephrol       Date:  2008-04

Review 7.  Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.

Authors:  Katherine F Croom; Monique P Curran; Karen L Goa; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.

Authors:  Thomas E Delea; Oleg Sofrygin; James L Palmer; Helen Lau; Veronica C Munk; Jennifer Sung; Alan Charney; Hans-Henrik Parving; Sean D Sullivan
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

9.  Diabetes in Navajo youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.

Authors:  Dana Dabelea; Joquetta DeGroat; Carmelita Sorrelman; Martia Glass; Christopher A Percy; Charlene Avery; Diana Hu; Ralph B D'Agostino; Jennifer Beyer; Giuseppina Imperatore; Lisa Testaverde; Georgeanna Klingensmith; Richard F Hamman
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

10.  Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.

Authors:  Ronny A Bell; Elizabeth J Mayer-Davis; Jennifer W Beyer; Ralph B D'Agostino; Jean M Lawrence; Barbara Linder; Lenna L Liu; Santica M Marcovina; Beatriz L Rodriguez; Desmond Williams; Dana Dabelea
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.